Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional Results available

Safety & Efficacy Study Evaluating the Combination of Bevasiranib & Lucentis Therapy in Wet AMD

ClinicalTrials.gov ID: NCT00499590

Public ClinicalTrials.gov record NCT00499590. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 24, 2026, 12:32 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Randomized, Double-masked, Parallel-assignment Study of Intravitreal Bevasiranib Sodium, Administered Every 8 or 12 Weeks as Maintenance Therapy Following Three Injections of Lucentis® Compared With Lucentis® Monotherapy Every 4 Weeks in Patients With Exudative Age-Related Macular Degeneration (AMD).

Study identification

NCT ID
NCT00499590
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
OPKO Health, Inc.
Industry
Enrollment
338 participants

Conditions and interventions

Interventions

  • bevasiranib Drug
  • ranibizumab Drug

Drug

Eligibility (public fields only)

Age range
50 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 31, 2007
Primary completion
Feb 28, 2009
Completion
Apr 30, 2009
Last update posted
Oct 5, 2014

2007 – 2009

United States locations

U.S. sites
55
U.S. states
24
U.S. cities
50
Facility City State ZIP Site status
Retinal Consultants of Arizona (site 209) Phoenix Arizona 85014
Associated Retina Consultants (site 286) Phoenix Arizona 85020
Retina Centers PC (site 215) Tucson Arizona 85704
Eye Medical Center (site 287) Fresno California 93720
Northern California Retina Vitreous Associates (site 320) Mountain View California 94040
Retina Institute of California (site 207) Pasadena California 91105
Retina Consultants San Diego (site 232) Poway California 93064
Retinal Consultants Medical Group (site 289) Sacramento California 95819
Orange County Retina Medical Group (site 252) Santa Ana California 92705
Miramar Eye Specialists Medical Group (site 245) Ventura California 93003
The Eye Care Group, PC (site 315) Waterbury Connecticut 06708
Florida Eye Clinic (site 257) Altamonte Springs Florida 32701
Florida Eye Microsurgical Institute, Inc. (site 217) Boynton Beach Florida 33426
Retina Health Center (site 247) Fort Myers Florida 33901
National Ophthalmic Research Institute at Retina Consultants of SW Florida (site 270) Fort Myers Florida 33912
Magruder Eye Institute (site 264) Orlando Florida 32803
Southern Vitreoretinal Associates, PL (site 309) Tallahassee Florida 32308
University of South Florida Eye Institute (site 311) Tampa Florida 33612
Center for Retina and Macular Disease (site 293) Winter Haven Florida 33880
Southeast Retina Center (site 268) Augusta Georgia 30909
Midwest Eye Institute (site 253) Indianapolis Indiana 46280
Retina Associates, PA (site 295) Shawnee Mission Kansas 66204
Vitreo-Retinal Consultants & Surgeons, P.A. (site 274) Wichita Kansas 67214
Eye Centers of Louisville (site 251) Louisville Kentucky 40207
Retina Specialists (site 231) Towson Maryland 21204
Retina Associates St. Louis (site 300) Florissant Missouri 63031
Eye Foundation of Kansas City Truman Medical Center (site 272) Kansas City Missouri 64108
Retinal Consultants of Nevada (site 273) Las Vegas Nevada 89144
Eyesight Ophthalmic Services, PA (site 290) Portsmouth New Hampshire 03801
Delaware Valley Retina Associates (site 261) Lawrenceville New Jersey 08648
Retina-Vitreous Consultants (site 216) Livingston New Jersey 07039
Retina Associates of New Jersey (site 298) Teaneck New Jersey 07666
Capital Region Retina (site 316) Albany New York 12206
New York Eye & Ear Infirmary (site 272) New York New York 10003
Vitreous-Retina-Macula Consultants of New York (site 239) New York New York 10022
Carolina Eye Associates (site 308) Southern Pines North Carolina 28387
Retina Associates of Cleveland (site 228) Beachwood Ohio 44122
Cincinnati Eye Institute (site 285) Cincinnati Ohio 45242
Retina Associates of Cleveland, Inc. (site 219) Lakewood Ohio 44107
Retina-Vitreous Associates (site 266) Toledo Ohio 43608
Retina and Vitreous Center of Southern Oregon (site 271) Ashland Oregon 97520
Ophthalmology Associates of PA (site 297) Bala-Cynwyd Pennsylvania 19004
Palmetto Retina Center (site 275) West Columbia South Carolina 29169
Black Hills Regional Eye Institute (site 202) Rapid City South Dakota 57701
Southeastern Retina Associates, PC (Site 250) Knoxville Tennessee 37909
Retina Research Institute of Texas, L.L.C. (site 269) Abilene Texas 79606
Austin Retina Associates (site 304) Austin Texas 78705
Retina Research Center (site 204) Austin Texas 78705
University of Texas Medical Branch- Galveston (site 301 Galveston Texas 77555
Houston Eye Associates (site 321) Houston Texas 77025
Valley Retina Institue, PA (site 258) McAllen Texas 78503
Eye Care Associates of East Texas (site 282) Tyler Texas 75701
Rocky Mountain Retina Consultants (site 256) Salt Lake City Utah 84107
University of Utah, John A. Moran Eye Center (site 205) Salt Lake City Utah 84132
University of Virginia- Ophthalmology Dept. (site 254) Charlottesville Virginia 22908

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 5 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00499590, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 5, 2014 · Synced Jul 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00499590 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →